A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/1997
12/17/1997	EP0812198A1 Storage-stable prostaglandin compositions
12/17/1997	EP0812195A1 Pharmaceutical composition for piperidinoalkanol compounds
12/17/1997	EP0812187A1 Redispersible nanoparticulate film matrices with protective overcoats
12/17/1997	EP0652896B1 Peptide compounds
12/17/1997	EP0616528B1 Implantable capsule
12/17/1997	EP0612251B1 Stabilised antibodies
12/17/1997	EP0607332B1 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
12/17/1997	EP0593601B1 Novel compositions based on taxane class derivatives
12/17/1997	CN1168146A Stabiliser mixture made from chromane derivs. and inert organic solvents, and microcapsules contg. said stabiliser mixture
12/17/1997	CN1168094A Directly compressible high load acetaminophen formulations
12/17/1997	CN1167777A Interferon conjugates
12/17/1997	CN1036699C Silica ketoconazole ointment and its preparing method
12/16/1997	US5698786 Sensing apparatus for generating an output signal
12/16/1997	US5698721 Catonic amphiphiles
12/16/1997	US5698685 Morpholino-subunit combinatorial library and method
12/16/1997	US5698661 High molecular weight polyesterpolycarbonates and the use thereof for the preparation of bioerosible matrices
12/16/1997	US5698649 Hair sprays, thickeners for aqueous systems, cosmetics, dentifrices
12/16/1997	US5698589 Water-based topical cream containing nitroglycerin and method of preparation and use thereof
12/16/1997	US5698582 Injectable solution; dissolved in polysorbate or polyethoxylated castor oil; ethanol-free
12/16/1997	US5698535 SIN-1A cyclodextrin inclusion complexes
12/16/1997	US5698533 Mixing warm water with a hydrocarbonaceous semi-solid or oil containing a drug, atomizing and applying to the eye in the form of liquid drops; eliminates the need for chloroflurocarbon propellants
12/16/1997	US5698531 Delivering a dna sequence encoding a therapeutic or diagnostic protein by catheterization to a discrete blood vessel segment using genetically engineered or normal cells or vector systems; drug delivery
12/16/1997	US5698529 Chemotherapeutic compositions
12/16/1997	US5698515 Insulin-containing polymer composition for oral administration
12/16/1997	US5698436 Introduction and expression of foreign genetic material in epithelial cells
12/16/1997	US5698424 Capsid forming and cystein modified chimaeric MS2-coat protein
12/16/1997	US5698405 Coupling immunogenic agent with a carbohydrate polymer
12/16/1997	US5698226 Water-dispersible tablets
12/16/1997	US5698224 Osmotic dosage form
12/16/1997	US5698221 Containing 2-amino-2-(4-methylpiperazin-1-ylzzzz0-5-(2,3,5-trichlorophen yl)pyrimidine
12/16/1997	US5698216 Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof
12/16/1997	US5698207 Burn treatment composition
12/16/1997	US5698178 Binding a multidrug transporter protein and an antigen associated with a tumor or infectious agent
12/16/1997	US5697902 Treating patient with antibody or antibody fragment conjugated to cytotoxic agent
12/16/1997	CA2109623C Process for solubilizing difficultly soluble pharmaceutical actives
12/11/1997	WO1997046671A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	WO1997046589A2 Humanized antibodies that bind to the same antigen as bound by antibody nr-lu-13, and their use in pretargeting methods
12/11/1997	WO1997046572A1 Transgenic animals expressing artificial epitope-tagged proteins
12/11/1997	WO1997046262A2 Membrane incorporation of texaphyrins
12/11/1997	WO1997046261A1 Process for producing drug complexes
12/11/1997	WO1997046260A1 Drug complexes
12/11/1997	WO1997046259A2 Chimeric toxin for targeted therapy
12/11/1997	WO1997046258A1 Cosmetic and/or pharmaceutical emulsions containing behenyl derivatives
12/11/1997	WO1997046246A1 Complex preparations characterised by a betain content
12/11/1997	WO1997046224A1 Enteric coating, comprising alginic acid, for an oral preparation
12/11/1997	WO1997046223A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
12/11/1997	WO1997046222A1 Pediatric formulation for hiv protease inhibitors
12/11/1997	WO1997046100A1 Serpin enzyme complex receptor-mediated gene transfer
12/11/1997	WO1997046099A1 Liver retention clearing agents
12/11/1997	WO1997046098A1 Cluster clearing agents
12/11/1997	WO1997041843A3 Medicated chewing gum with a pleasant taste containing an inclusion complex
12/11/1997	DE19623916A1 3 betaÝN-(N,N'-di:methyl aminoethane)-carbamoyl¨cholesterol
12/11/1997	CA2257559A1 Complex preparations characterised by a betain content
12/11/1997	CA2257363A1 Cluster clearing agents
12/11/1997	CA2257353A1 Liver retention clearing agents
12/11/1997	CA2257245A1 Drug complexes
12/11/1997	CA2257233A1 Process for producing drug complexes
12/11/1997	CA2257225A1 Membrane incorporation of texaphyrins
12/11/1997	CA2256558A1 Serpin enzyme complex receptor-mediated gene transfer
12/11/1997	CA2256456A1 Enhanced efficacy of liposomal antisense delivery
12/11/1997	CA2253262A1 Transgenic animals expressing artificial epitope-tagged proteins
12/11/1997	CA2228444A1 Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
12/10/1997	EP0811846A2 Stabilisation of metal conjugates
12/10/1997	EP0811386A2 Method of selecting a salt for making an inclusion complex
12/10/1997	EP0811385A2 Conjugate of a factor specifically recognizing interleukin-2 receptor with ribonuclease
12/10/1997	EP0811381A1 A novel composition for transdermal administration of an estrogen, a progestin or a mixture thereof
12/10/1997	EP0811374A1 Combination dosage form comprising cetirizine and pseudoephedrine
12/10/1997	EP0811160A1 Nf-kappa b activation regulatory protein, i-kappa b-beta
12/10/1997	EP0811065A1 Antagonists of interleukin-15
12/10/1997	EP0810975A2 Method of producing hydrophilic or partially hydrophilic inorganic aerogels
12/10/1997	EP0810883A2 Individual medicament dosing conjugate
12/10/1997	EP0810880A1 Pharmaceuticals and assays using enzyme subunits
12/10/1997	EP0810868A1 Use of piperine as a bioavailability enhancer
12/10/1997	EP0810865A1 Novel pharmaceutical composition
12/10/1997	EP0810855A1 Polyalkylene block copolymers as surface modifiers for nanoparticles
12/10/1997	EP0810854A1 Aerosols containing beclomethazone nanoparticle dispersions
12/10/1997	EP0810822A1 Use of aerogels in agriculture
12/10/1997	EP0781135A4 Codeine containing formulations
12/10/1997	EP0775173A4 Starch-bound cellular matrix
12/10/1997	EP0684808B1 Light stable color compositions
12/10/1997	EP0660702B1 Water-in-oil emulsions containing water-soluble alkyl glycosides
12/10/1997	EP0417209B1 Compositions and methods for administering therapeutically active compounds
12/10/1997	CN1167505A Tie-2 ligands, methods of making and uses thereof
12/10/1997	CN1167126A Blends containing absorbable polyoxaamides
12/09/1997	US5696298 Polyoxypropylene/polyoxyethylene copolymers with improved biological activity
12/09/1997	US5696249 Nucleic acid ligands
12/09/1997	US5696237 Recombinant antibody-toxin fusion protein
12/09/1997	US5696172 Containing complexing agent, preservative and ph adjuster to maintain ph between 7.5 and 8.5 for oxidation resistance and storage stability
12/09/1997	US5696164 Antifungal treatment of nails
12/09/1997	US5696105 Antifungal nail composition
12/09/1997	US5696095 Contains potassium acesulfame; masks bitterness without adversely affecting bioavailability or stability
12/09/1997	US5696090 Pharmaceutical composition
12/09/1997	US5696077 Pharmaceutical composition containing botulinum B complex
12/09/1997	US5695955 Analogs of parathyroid hormone and parathyroid hormone related peptide: synthesis and use for the treatment of osteoporosis
12/09/1997	US5695784 Flavor-masked pharmaceutical compositions
12/09/1997	US5695781 Sustained release formulation containing three different types of polymers
12/09/1997	US5695771 Applying to skin to inhibit the peroxidation of lipids
12/09/1997	US5695770 Induction of cytotoxic T-lymphocyte responses
12/09/1997	US5695768 Immunostimulating activity of Streptococcus pneumoniae serotype 8 oligosaccharides
12/09/1997	US5695760 Modified anti-ICAM-1 antibodies and their use in the treatment of inflammation

1 ... 1480 1481 1482 1483 1484 1485 1486 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 ... 1712